Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Bioventus (BVS) Shares Issued (2021 - 2025)

Bioventus' Shares Issued history spans 5 years, with the latest figure at $511000.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 53.67% year-over-year to $511000.0; the TTM value through Dec 2025 reached $2.1 million, down 15.07%, while the annual FY2025 figure was $2.1 million, 15.07% down from the prior year.
  • Shares Issued reached $511000.0 in Q4 2025 per BVS's latest filing, up from $96000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $107.8 million in Q3 2021 to a low of $16000.0 in Q2 2021.
  • Average Shares Issued over 5 years is $6.6 million, with a median of $496500.0 recorded in 2022.
  • The largest YoY upside for Shares Issued was 12900.0% in 2022 against a maximum downside of 97.98% in 2022.
  • A 5-year view of Shares Issued shows it stood at $107.8 million in 2021, then tumbled by 98.99% to $1.1 million in 2022, then plummeted by 85.41% to $158000.0 in 2023, then surged by 598.1% to $1.1 million in 2024, then plummeted by 53.67% to $511000.0 in 2025.
  • Per Business Quant, the three most recent readings for BVS's Shares Issued are $511000.0 (Q4 2025), $96000.0 (Q3 2025), and $1.3 million (Q2 2025).